Category Archives: Stem Cell Research

Persuasive Speech-Jared Volz-Stem Cell Research FOC Persuasive Speech for Fundamentals of Oral Communications over Stem Cell Research. By: Jared Volz … Continue reading →

Dental Talk Show - Dental Stem Cells, Dental Show Preview Competition News Host Nick Peters discusses Stem cell research and how the use of Stem Cells from Teeth are showing promising potential in the use of Stroke Therapy due to there likeness of Brain Neurons. #DentalNe... By: NIck Peters … Continue reading →

Stem Cells 101 and Beyond Divya Mathur and Chris Lengner from Rudolf Jaenisch's lab at the Whitehead Institute discuss the basics of stem cell research, as well as their latest findings. By: Forum Network … Continue reading →

MANILA - Only three stem cell procedures are now allowed in the Philippines as the Food and Drug Administration (FDA) rejected the registration of other stem cell products. FDA director general Kenneth Hartigan-Go said only the use of stem cells in hematopoietic transplantation, corneal resurfacing with limbal stem cells, and skin regeneration with epidermal stem cells are recognized by the FDA as acceptable or standard healthcare procedures. Go said other stem cell therapies are considered illegal. In an advisory, Go also said that not one stem cell or tissue-based product (HCT/Ps) had been registered by the FDA for compassionate or clinical trial use or for general use. Those who want to do stem cell outside of the three approved indications will have to register, either for compassionate use or clinical trial (as) these are the ones we inspect, he added. The FDA official cited lack of evidence of technical competence, procedures and documentations based on Current Good Manufacturing Practices and Current Good Laboratory Practices in denying the applications. The applications also did not have ethical review procedures and systems accredited by the Philippine Health Research Ethics Board, the national accreditation body of the Department of Science and Technology, and had … Continue reading →

By Estel Grace Masangkay An independent group of scientists led by experts at the New York Stem Cell Foundation Research Institute (NYSCF) reported that they have manufactured the first disease-specific line of embryonic stem cells made with a patients DNA. The achievement is heralded as a major breakthrough in the regenerative medicine field. This is also the first time cloning technologies have been utilized to generate genetically matched stem cells. The team used somatic cell nuclear transfer to successfully clone a skin cell from a 32 year old female patient with Type 1 diabetes. The cells were transformed into insulin-producing cells similar to lost beta cells in diabetes, which could provide better treatment or even a cure for T1D. Susan Solomon, CEO and co-founder of NYSCF, says she is excited about the successful production of patient-specific stem cells using somatic cell nuclear transfer (SCNT). CEO Solomon said she became involved with medical research when her son was diagnosed with T1D. Dr. Egli, scientist from the New York Stem Cell Foundation Research Institute and who led the research, said, From the start, the goal of this work has been to make patient-specific stem cells from an adult human subject with type-1 … Continue reading →

Stem Cell Research Human Dignity A preview of Moral Compass : Stem Cell Research Human Dignity This is a free preview of the full episode; to see the full version, sign up for a Premium ac... By: ChurchMilitantTV … Continue reading →

Stem Cell Research Public Service Announcement Digital PSA for University of Kentucky's WRD111 Course. Songs: Fix You - Coldplay Beautiful Day - U2 (used without permission) Works Cited "Neuralstem Cell T... By: Kirstie Kleiner … Continue reading →

Stem Cell Research Period 2 Biology. By: Abby7674 … Continue reading →

17 hours ago Figure 1: Fluorescence microscopy image of cells cultured on soft (left) and rigid (right) substrates. Actin filaments (red) in these cells display dramatic differences in number and organization depending on substrate elasticity. Credit: The Society for Biotechnology, Japan Converting adult cells into stem cells that can develop into other types of specialized cells is one of the most active areas of medical research, holding great promise for the treatment of disease and repair of damaged tissues. The techniques available for reprogramming adult cells into stem cells, however, remain imperfect and inefficient. In research that could help improve reprogramming efficiency, Sayaka Higuchi and colleagues from the RIKEN Quantitative Biology Center have now found that culturing cells on soft or elastic substrates enhances expression of some of the markers of stem cell reprogramming. Motivated by previous observations that culturing cells on soft surfaces can affect their ability to multiply and renew, Higuchi and her team set out to examine whether the same principle might be applicable to enhancing the efficiency of producing induced pluripotent stem (iPS) cellsa type of stem cell that is reprogrammed from mature adult fibroblast cells using methods such as the introduction of genetic factors. The … Continue reading →

PUBLIC RELEASE DATE: 1-May-2014 Contact: Krista Conger kristac@stanford.edu 650-725-5371 Stanford University Medical Center STANFORD, Calif. Stem cells made from the skin of adult, infertile men yield primordial germ cells cells that normally become sperm when transplanted into the reproductive system of mice, according to researchers at the Stanford University School of Medicine and Montana State University. The infertile men in the study each had a type of genetic mutation that prevented them from making mature sperm a condition called azoospermia. The research suggests that the men with azoospermia may have had germ cells at some point in their early lives, but lost them as they matured to adulthood. Although the researchers were able to create primordial germ cells from the infertile men, their stem cells made far fewer of these sperm progenitors than did stem cells from men without the mutations. The research provides a useful, much-needed model to study the earliest steps of human reproduction. "We saw better germ-cell differentiation in this transplantation model than we've ever seen," said Renee Reijo Pera, PhD, former director of Stanford's Center for Human Embryonic Stem Cell Research and Education. "We were amazed by the efficiency. Our dream is to use this model … Continue reading →